The ram locus, consisting of the romA-ramA genes, is repressed by the tetracycline-type regulator RamR, where regulation is abolished due to loss-of-function mutations within the protein or ligand interactions. The aim of this study was to determine whether the phenothiazines (chlorpromazine and thioridazine) directly interact with RamR to derepress ramA expression.
Introduction
The TetR-family regulators (TFRs) are one of the most ubiquitous transcriptional regulatory families and are involved in myriad processes, including catabolic pathways, antimicrobial resistance and virulence. 1 Typically TFR proteins consist of N-terminal DNA binding and C-terminal ligand binding domains where transcriptional repression by TFRs can be alleviated by the transient binding of small molecule ligands to the C-terminal domain, which facilitates the interaction of single TFRs with structurally dissimilar ligands, thereby enabling a single protein to regulate expression of target gene loci in response to a number of different signals. 1, 2 In Klebsiella pneumoniae, TetR-family regulators such as AcrR and RamR control loci that are associated with the microbe's intrinsic response to stress. 3, 4 The intrinsic ram locus encoded by the ramR -romA -ramA genes first described in K. pneumoniae 5 includes RamA, which functions as a pleiotropic regulator of gene expression. 6 RamR, a TetR-family repressor, negatively regulates transcription of both the romA and ramA genes ( Figure 1 ) by binding the conserved inverted repeat sequence (ATGAGTG-N 6 -CACTCAT) (Figure 1 ), which overlaps the romA -ramA transcriptional start site within the promoter region. 3 Multiple studies of clinically drug-resistant K. pneumoniae demonstrate that derepression of the romA -ramA genes generally arise from mutations within RamR.
3,7 Thus, mutational derepression was regarded as the sole mechanism of increased ramA expression. However, the recently elucidated RamR crystal structure 8 provides direct evidence that RamR -ligand interactions can also result in the derepression of ramA gene transcription. Previous work in Salmonella enterica serovar Typhimurium has shown that the tricyclic antipsychotic (phenothiazine) agent chlorpromazine induces ramA expression, whilst ramA deletion mutants exhibit increased chlorpromazine susceptibility. 9 More recent data suggest that inducers of ramA expression in Salmonella are likely to be compounds that inhibit the expression levels of the efflux pump acrAB.
9 However, it is not clear whether ramA up-regulation is triggered by the direct interaction of RamR with the inducer compounds or tertiary regulatory factors. Therefore, the molecular basis of ramA up-regulation remains to be described.
Tricyclic antipsychotic (phenothiazine) agents, such as chlorpromazine and thioridazine, have been associated with potentiation of antibiotic activity, 10 including the tetracyclines chloramphenicol and fluoroquinolones, 11 against several different bacterial species.
12 Further studies investigating the basis of phenothiazine-mediated increases in susceptibility suggest that these compounds alter membrane-associated structures or the bacterial membrane itself; however, their exact cellular targets remain largely unknown.
11 Importantly, the widespread use of phenothiazine drugs and the likely environmental persistence of transformed phenothiazine metabolites 13 could impose selection, thus facilitating the development of antimicrobial resistance.
In this study, we investigated the effect of chlorpromazine or thioridazine exposure on ramA expression in K. pneumoniae, and demonstrated the involvement of direct interactions with RamR in this process. Our results showed that K. pneumoniae RamR interacts directly with both of these phenothiazines, resulting in a transient induction of the romA-ramA genes, the expression of which is restored to near basal concentrations in the absence of these stimuli. Thus, phenothiazines can trigger a non-mutational transient derepression of the ram locus, which results directly from RamR -phenothiazine interactions.
Materials and methods

Bacterial strains and propagation
K. pneumoniae Ecl8 is as described by Forage and Lin. 14 The genome sequence of this strain was recently described. 15 Bacteria were grown in LB broth with shaking or on agar (Sigma-Aldrich, UK) at 378C. Chlorpromazine or thioridazine (Sigma-Aldrich, UK) was added at 150 mg/L as required.
Drug susceptibility
Susceptibility assays were performed as per the BSAC standardized broth microdilution method. 16 Briefly, overnight cultures were diluted to 10 4 dilutions in PBS medium, and 5 mL of the diluted culture was spotted onto LB agar plates supplemented with the different antibiotics and phenothiazines. All tests were undertaken in duplicate.
PCR and genome sequencing
The ramR gene was amplified from cell lysates of K. pneumoniae Ecl8 untreated and treated with chlorpromazine or thioridazine at 150 mg/L for 1 h. The primers used are listed in Table 1 . The PCR-amplified fragments were sequenced bidirectionally at GATC, Germany.
RamR expression and purification
RamR, overexpressed from the ramR gene cloned into the pET28a vector, was purified using metal chelation chromatography using the 6-His-tag under denaturing conditions as previously described. De Majumdar et al.
Purified His 6 -RamR was dialysed into storage buffer (50 mM Tris -HCl pH 7.5, 0.1 mM EDTA, 150 mM NaCl, 0.1% b-mercaptoethanol, 270 mM sucrose, 0.03% Brij-35, 1 mM benzamidine and 0.2 mM PMSF).
RNA extraction
RNA was extracted from K. pneumoniae Ecl8 following exposure to chlorpromazine, thioridazine or sterile distilled water, using the TRIzol extraction method as described previously. 3 Briefly, K. pneumoniae Ecl8 cells were grown to mid-log phase (OD 600 ¼0.6) at 378C with shaking, followed by exposure to different concentrations of either chlorpromazine or thioridazine for a further 30 min. The cells were then harvested by centrifugation at 3200 g at 48C. For reviving the cells post-exposure to chlorpromazine or thioridazine, the cell pellet was washed with fresh medium and grown at 378C with shaking for another 30 min. The cell pellet was then resuspended in TRIzol reagent (Invitrogen, Paisley, UK) for subsequent RNA extraction. The resulting pellet was washed and resuspended in 50 mL of DEPC-treated water. RNA derived from bacteria exposed to sterile distilled water was considered as a control as both chlorpromazine and thioridazine were dissolved in water.
Quantitative real-time PCR (qPCR)
In order to determine whether chlorpromazine and thioridazine would result in ramA, romA and acrA up-regulation, qPCR analyses were performed on RNA extracted from K. pneumoniae Ecl8. Briefly, extracted RNA from samples was subjected to DNAse I (Ambion, UK) digestion prior to cDNA synthesis using the Affinity Script cDNA synthesis kit (Agilent, UK). The resulting cDNA was amplified using the Brilliant III SYBR Green kit (Agilent, UK) in the Stratagene MxPro PCR system. Undiluted cDNA was used to assess the levels of test gene expression and a 10-fold dilution was used to determine 16S concentrations (normalizer). The relative increase in gene expression was determined by normalization to 16S rRNA concentrations then calibration to concentrations measured in the unchallenged K. pneumoniae Ecl8 samples. All primers (Table 1 ) used in the qPCR experiments were validated for efficiency by determining the standard (95%-110%) and melting curve values.
Electrophoretic mobility shift assays (EMSAs)
The P I promoter fragment (296 bp) for EMSAs was amplified from K. pneumoniae Ecl8 genomic DNA with primers P I XbaI and romAR4 (Table 1) , as described previously.
3 The resulting DNA fragment was used in EMSA after end labelling using [g- Labelled PCR products (2 nM) were incubated with 2 mM RamR in binding buffer (125 mM Tris -HCl, 250 mM KCl, 5 mM DTT, 160 ng/mL salmon sperm DNA and 25% glycerol) and chlorpromazine or thioridazine at 150 mg/L (molarity conversion is 420 mM chlorpromazine and 370 mM thioridazine). Stock solutions of chlorpromazine and thioridazine were made in sterile distilled water. Complexes were run on 5% native PAGE gels at 75 V for 2.5 h in 1× TBE buffer. The gel was then dried and exposed to the phosphor screen for image analyses.
In vitro transcription
Experiments were undertaken as described previously. 17 The resulting products were electrophoresed on a 7% polyacrylamide/8 M urea gel. Quantification of either an increase or a decrease in transcription was 
Biophysical experiments
All biophysical measurements were carried out in 20 mM sodium phosphate pH 8.0 at 258C. Recombinant RamR purified as above was diluted into this buffer to 1.5 mg/mL and desalted on a 2.5 mL Sephadex G-25 column (GE Life Sciences PD-10). Protein concentrations were determined spectrophotometrically using an extinction coefficient of 22 585 M 21 cm
21
calculated from the amino acid sequence according to the method of Gill and von Hippel. 18 Circular dichroism spectra of RamR (7.25 mM) in the presence of ligands (500 mM) were measured using a J-810 spectropolarimeter (Jasco UK, Great Dunmow, Essex, UK). Data were acquired as the means of 10 scans and plotted after correction to background (buffer or ligand only) spectra. Secondary structure (a helical) content was estimated from the mean residue ellipticity measured at 222 nm by the method of Rohl and Baldwin. 19 Fluorescence measurements were carried out on a Fluorolog spectrofluorimeter (Horiba UK, Stanmore, Middlesex, UK), titrating ligands into 5 mM RamR in a stirred 1 mL quartz cuvette. The excitation wavelength was 280 nm and the emission wavelength was 330 nm. Samples were equilibrated for 2 min after each addition and fluorescence was measured as the mean of five individual integrations. Data were corrected for dilution and fitted to the tight binding quadratic equation.
where F, F init and DF denote measured fluorescence, maximal fluorescence and maximal change in fluorescence, respectively, [P 0 ] is the concentration of RamR (fixed at 5 mM), [L] is the concentration of ligand and K d is the dissociation constant.
Molecular docking
Docking of chlorpromazine and thioridazine compounds into the RamR crystal structure (PDB code: 3VW2) was performed using the Glide 5.8 module of Schrö dinger software. 21 The Glide docking box was centred on berberine, the ligand complexed with RamR in the crystal structure. The Glide default settings with the extra-precision scoring option were used for docking. Both ligands were docked in a similar fashion in all 10 poses, having p-p stacking interactions with F155. Images were prepared using the Maestro 9.3.5 interface. 22 
Results
Phenothiazine-mediated effects on MICs
The relative phenothiazine susceptibilities alone or in combination with antibiotics were tested against the wild-type or mutants deleted for ramA or ramR. Generally there was at least a 2-fold reduction in the MIC values in the presence of either chlorpromazine or thioridazine. However, the decrease in MICs for the ramA overexpresser strain Ecl8DramR, was less than that reported for either Ecl8 or Ecl8DramA (Table 2) . Interestingly, chlorpromazine was found to have a greater effect on potentiating antibiotic activity compared with thioridazine.
qPCR
To investigate a possible involvement of tricyclic phenothiazines in modulating expression of the K. pneumoniae ram locus we first used qPCR to examine the effects of chlorpromazine or thioridazine exposure upon transcript levels of the ramA and romA genes (Figure 2a) show that 100 mg/L (280 mM) chlorpromazine up-regulates expression of both target genes by more than 4 log 2 -fold, while 100 mg/L (250 mM) thioridazine induces an increase of 5 -6 log 2 -fold in ramA, and a lower (3-4 log 2 -fold) increase in romA, expression relative to untreated controls. Further experiments identified a concentration of 150 mg/L (420 mM chlorpromazine and 370 mM thioridazine) (Figure 2a) to be the concentration necessary to achieve maximum changes (6 log 2 -fold increase) in ramA expression. The possibility that this represents part of an overall increase in transcription as a component of a more generalized stress response was investigated by measuring transcript levels for 'housekeeping' genes such as gapA or gnd whose expression is known to be independent of RamA.
3 Levels of both the gapA and gnd gene products were unaltered (data not shown). We next determined whether the phenothiazine-mediated effect resulted in either a constitutive or a transient induction of the ram locus. Using a strategy of transient phenothiazine exposure (1 h) followed by revival in normal culture medium, qPCR analyses were performed to assess ramA concentrations. Exposure to chlorpromazine or thioridazine alone resulted in a 5 -6 log 2 -fold increase in gene expression, which was abolished or reduced when cells were exposed to the phenothiazines followed by revival in fresh medium, thereby suggesting that the possible RamR-phenothiazine-mediated induction of the ramA gene is reversible (Figure 2b) . However, compared with chlorpromazine, there is only a 2-fold reduction in ramA expression levels after revival post-thioridazine exposure, suggesting that the thioridazine-mediated effect may be due to stronger thioridazine -RamR interactions. To confirm that this effect represents a transient and reversible mechanism of ramA derepression, we performed DNA sequence analyses on the ramR gene from cultures obtained after phenothiazine exposure for 1 h. Our data demonstrate that there are no mutations introduced within the ramR gene sequence ( Figure S1 , available as Supplementary data at JAC Online).
EMSAs
On the basis of these data we hypothesized that increased transcription of the romA-ramA genes is associated with derepression of the ram locus, and that this could arise from the effect of direct interaction of chlorpromazine or thioridazine with the RamR protein. Accordingly, we investigated whether either chlorpromazine or thioridazine was able to affect the binding of purified recombinant RamR protein to a 296 bp DNA fragment containing the P I promoter (Figure 1 ) under EMSA conditions [ Figure 3 and Figure S2 (available as Supplementary data at JAC Online)]. EMSAs show that 2 mM RamR is sufficient to achieve maximal binding to a DNA fragment containing the 296 bp P I promoter (data not shown). Importantly, this binding is specific, as shown in Figure S2 . However, addition of either chlorpromazine or thioridazine (150 mg/L) to the system completely abolishes binding of RamR to DNA (Figure 3) , indicating that the RamR-ligand interaction impacts the binding interaction of RamR with the P I promoter.
In vitro transcription
To ascertain if ligand-mediated interaction would also directly impact on the repressive role of RamR, in vitro transcription experiments were undertaken to investigate the impact of chlorpromazine or thioridazine on repression of the P I promoter by RamR Expression levels of the ramA and romA genes were determined after K. pneumoniae Ecl8 was exposed to either TDZ or CPZ.
Relative increases in expression levels were determined first after normalization to the 16S concentrations and then calibrated against the unchallenged K. pneumoniae Ecl8. romA and ramA concentrations after exposure to CPZ or TDZ at concentrations ranging from 100 to 200 mg/L (i.e. 250 -490 mM for TDZ and 280 -560 mM for CPZ). (b) Reviving the treated cells. Cells exposed to CPZ or TDZ were washed and then revived with fresh medium. Expression levels of the ramA and romA genes were determined after K. pneumoniae Ecl8 was exposed to either 150 mg/L TDZ or CPZ. Relative increases in expression levels were determined firstly after normalization to the 16S concentrations and then calibrated against the unchallenged K. pneumoniae Ecl8. Statistical significance was determined using one-way ANOVA. ). The results demonstrate that purified RamR reduces transcription of the P I promoter to 19% of the concentrations measured in the positive control (from which RamR is absent; Figure 4 ). However, the addition of chlorpromazine or thioridazine restored transcriptional activity to 80% or 59%, respectively, of controls. The addition of chlorpromazine or thioridazine alone did not impact on the transcriptional outcome in the presence of RNA polymerase.
Biophysical investigations of RamR-ligand interactions
To investigate interactions of purified recombinant RamR with chlorpromazine or thioridazine we used both circular dichroism ( Figure S3 , available as Supplementary data at JAC Online) and fluorescence spectroscopy (Figure 5a ) analyses. Importantly, recombinant (hexa-histidine tagged) RamR correctly refolded after purification under denaturing conditions as judged by circular dichroism spectroscopy ( Figure S3 ), with the far-UV circular dichroism spectrum resembling those previously obtained for other TetR family proteins such as Streptomyces coelicolor ActR. 23 The mean residue ellipticity value at 222 nm indicates that over 50% of amino acids in the protein backbone are in an a-helical conformation. Both ligands induce a clear reduction in the secondary structure content of RamR compared with RamR alone ( Figure S3 ). Titrations monitoring the intrinsic (tryptophan) fluorescence of RamR in the presence of phenothiazine ligands demonstrate a saturable reduction in fluorescence that may be fitted to yield dissociation constants of 1.5+0.41 and 3.7+0.12 mM for chlorpromazine and thioridazine binding, respectively (Figure 5a ). These data imply that both chlorpromazine and thioridazine bind directly and specifically to RamR. They also confirm that our EMSA and in vitro transcription experiments were carried out under saturating conditions, i.e. at ligand concentrations (420 mM chlorpromazine and 370 mM thioridazine) that are greatly in excess of the measured K d values (1.5 mM for chlorpromazine and 3.7 mM for thioridazine).
Molecular modelling of RamR-phenothiazine interactions
The crystal structures of RamR in complexes with several drugs are currently available, 8 facilitating the exploration of RamRphenothiazine interactions at an atomic level. Molecular docking into the RamR structure shows that thioridazine and chlorpromazine have similar binding poses within the RamR protein to those previously reported with other ligands. 8 The ligand phenothiazine ring forms a p -p stacking interaction with Phe155, similar to that adopted by other ligands present in available crystal structures of RamR (Figure 5b ). In addition, the protonated amine of both phenothiazines makes an ionic interaction with the RamR residue Asp152 at a distance between interacting atoms of 1.8 Å . The phenothiazine -RamR interaction is supported by stronger ionic interactions with the Asp152 and Lys63 residue. In contrast, in the available crystal structures RamR forms weak hydrogen bonds at a distance of 3.2 Å between the ligands ethidium bromide and berberine and Asp152 or Lys63.
8 Notably, none of the ligands reported in the available crystal structures 8 forms hydrogen bond interactions with the Lys63 residue. Thus, these additional polar contacts may provide a basis for the stronger binding of thioridazine and chlorpromazine to RamR (1.5 and 3.7 mM, respectively) compared with drugs in the crystal structures (14.6-26.4 mM).
8
Discussion
RamR, a TFR-type protein, is the repressor of the romA -ramA locus. Studies in Salmonella, 24 Klebsiella 3 and Enterobacter 7 have shown that inactivating mutations located throughout the RamR protein lead to the derepression of romA -ramA transcription and subsequently result in the multidrug-resistance phenotype. Whilst mutational deactivation of RamR resulting in increased ramA expression has been described previously, 3, 7, 24 a transient mechanism for ramA derepression has not been shown. The recently elucidated RamR -ligand crystal structures clearly demonstrate that structurally unrelated ligands can directly interact with the RamR protein, thus highlighting the possibility of a non-mutational mechanism for ramA expression.
8
In addition to their widespread use as antipsychotic drugs, phenothiazines such as chlorpromazine and thioridazine have been shown to increase bacterial susceptibility to certain antimicrobial classes when used in combination with specific antibiotics. 25 While this has been ascribed to a possible function as an Figure 4 . In vitro transcription experiments of the P I promoter in the presence of purified RamR, CPZ and TDZ. Levels of P I promoter transcription with purified RamR in the presence of CPZ and TDZ or CPZ and TDZ alone were measured. The reduction in repression in the presence of CPZ or TDZ is statistically significant (one-way ANOVA; ***P, 0.05) compared with the concentrations with P I +RamR only. Relative fold increases and decreases were determined using densitometric analyses as described previously, 3 by first normalizing all test (P I ) transcription concentrations to the control promoter (gnd) prior to comparison with the no-protein control presented as a percentage of total transcription. Data were derived from at least four experiments.
efflux pump inhibitor, studies in Salmonella also indicate effects on expression of both of the acrB efflux pump component 26 and its regulator ramA.
9 Our results demonstrate that exposure to the phenothiazines, chlorpromazine and thioridazine, has a similar effect on susceptibility and ramA overexpression levels in K. pneumoniae (Figure 2a) . However, our data also show that the ramA-overexpressing strain EclDramR is less susceptible to phenothiazine -antibiotic combinations than the wild-type parent, Ecl8, or the null mutant, Ecl8DramA, thus suggesting that ramA overexpression may contribute to a reduction in phenothiazine-associated inhibition of permeability factors.
The phenothiazine-mediated effect on ramA expression is reduced when the inducer is removed (Figure 2b) , suggesting a transient non-mutational effect. Whilst the removal of chlorpromazine restores the concentrations of ramA to basal concentrations, the effects of thioridazine-mediated exposure, post-revival, remain higher than expected, suggesting that the binding affinities of chlorpromazine and thioridazine to RamR may be different. Importantly, we demonstrated that the transient phenothiazine exposure does not result in ramR mutations ( Figure S1 ).
The RamR protein is central to repression of the romA -ramA locus in K. pneumoniae.
3 Consequently, the observed induction of ramA by phenothiazines led us to hypothesize that the increase in ramA transcription could result from direct interaction of RamR with these ligands. The data presented here confirm this hypothesis: addition of chlorpromazine or thioridazine abolishes binding of recombinant RamR to its promoter ( Figure 3 ) and directly impacts on ramA transcription (Figure 4) , while fluorescence measurements indicate that RamR can bind either ligand with micromolar affinity (Figure 5a ). Accordingly, we conclude that RamR interacts with both chlorpromazine and thioridazine (Figures 3  and 5a ) directly to derepress romA-ramA expression (Figure 4) .
The biophysical experimental results for RamR are consistent with recently published data for RamR 8 and also from other investigations for TFR proteins. 23, 27, 28 Our measured affinities are in the micromolar range, as has been reported for RamR binding to ligands such as ethidium bromide, berberine, Crystal Violet, 8 and other TFR family members such as the S. coelicolor ActR binding to derivatives of the polyketide actinorhodin, 23 of the catabolic intermediate phenylacetyl coenzyme A to Thermus thermophilus PaaR, 29 of the bile acid taurocholate to Campylobacter jejuni CmeR 28 and of ethidium bromide to the Mycobacterium tuberculosis transcriptional regulator Rv3066. Furthermore, the small change in the RamR circular dichroism spectrum that is observed in association with phenothiazine ligands ( Figure S3 ) is consistent with results reported for ActR, where a variety of ligands did not induce substantial changes in secondary structure. RamR -ligand interaction results in romA -ramA expression Finally, the molecular docking analyses of both thioridazine and chlorpromazine molecules into the RamR crystal structure reveal that the contacts made by both phenothiazines are consistent with the results described for other ligands, which interact with RamR.
7 From these analyses, it is evident that all the published ligands and the phenothiazines investigated here commonly interact with residues Tyr92, Cys134, Thr85 and Phe155 via hydrophobic and aromatic interactions. 7 However, unlike other RamR -ligand structures, where only Van der Waals or hydrogen bond contacts with residues Tyr92, Cys134, Thr85 and Phe155 were observed, both phenothiazines form an ionic interaction with Asp152 (Figure 5b ). Interestingly, a review of RamR mutations in ramA-overexpressing clinical strains of K. pneumoniae 3, 30, 31 indicates that the mutation located at position Asp152 also impacts on the DNA-binding function of RamR, resulting in the derepression of ramA concentrations.
In this work, we demonstrate that RamR directly interacts with the phenothiazines, thereby resulting in romA -ramA derepression in a transient manner, which may have implications for RamA-regulated phenotypes in K. pneumoniae and other related bacteria. Multiple studies now show that the phenotypic attribute of increased ramA expression in Salmonella 6 and Klebsiella (under review) is not limited to increased multidrug efflux, but is also linked to virulence traits. As such, despite a possible phenothiazine-mediated inhibition of permeability factors, the modifications associated with virulence attributes may remain unaffected. Thus physiological ligands that fulfil a similar function to the phenothiazines, or other, more structurally divergent, compounds that act as transient triggers of ramA expression may also regulate virulence in these bacteria.
